大理大学学报 ›› 2020, Vol. 5 ›› Issue (2): 50-55.DOI: 10. 3969 / j. issn. 2096-2266. 2020. 02. 011

• 药学 • 上一篇    下一篇

2015—2018年皖南医学院弋矶山医院麻醉药品应用分析

吴义来,潘荣华,汪魏平,徐文科*   

  1. (皖南医学院弋矶山医院药品供应保障科,安徽芜湖 241001)
  • 收稿日期:2019-05-17 修回日期:2019-09-05 出版日期:2020-02-15 发布日期:2020-02-15
  • 通讯作者: 徐文科,副主任药师,E-mail:xwk1970@ 126.com。
  • 作者简介:吴义来,药师,主要从事药物新剂型新技术研究。
  • 基金资助:
    皖南医学院中青年科研基金资助项目(WK2016F09)

Analysis on Application of Narcotic Drugs in Yijishan Hospital of Wannan Medical College#br# from 2015 to 2018

Wu Yilai, Pan Ronghua, Wang Weiping, Xu Wenke *   

  1. (Department of Pharmacy, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui 241001, China)
  • Received:2019-05-17 Revised:2019-09-05 Online:2020-02-15 Published:2020-02-15

摘要: 目的:分析皖南医学院弋矶山医院(以下简称“我院”)麻醉药品使用情况,为麻醉药品的科学管理和合理使用提供参
考。方法:对我院2015—2018年麻醉药物使用情况进行回顾性分析,依据世界卫生组织推荐日剂量分析法,对使用量、销售金
额、用药频度(defined daily dose system,DDDs)、限定日费用(defined daily cost,DDC)、排序比B/A(药品销售金额排序/DDDs排
序)等进行统计分析。结果:2015—2018年我院麻醉药品总使用量呈增长态势,口服缓控释制剂和外用贴剂用量和销售金额
增长明显,枸橼酸舒芬太尼注射液DDDs持续上涨,其他品种较为平稳,枸橼酸舒芬太尼注射液、盐酸羟考酮缓释片、硫酸
吗啡缓释片以及芬太尼透皮贴的DDC相对较高。2018年度麻醉药品各品种B/A值逐渐趋近1,表明经济效益和社会效益逐渐
同步。结论:我院麻醉药品销售金额逐年增长,临床使用基本符合相关标准和治疗规范,但仍需加强管理。

关键词: 麻醉药品, 用药频度, 限定日费用, 排序比, 应用分析

Abstract: Objective: To investigate the application of narcotic drugs in Yijishan Hospital of Wannan Medical College(hereinafter
referred to as "our hospital")from 2015 to 2018, so as to provide reference for the scientific management and rational application of
narcotics. Methods: Statistical analysis was conducted on the usage amount, consumption sum, defined daily dose system(DDDs),
defined daily cost(DDC)and B/A of narcotic drugs in our hospital from 2015 to 2018 according to defined daily dose(DDD)analysis
recommended by WHO. Results: From 2015 to 2018, the usage amount of narcotic drugs in our hospital had been increasing year by
year. The usage amount and consumption sum of oral sustained-release preparations and transdermal patches increased significantly.
The DDDs of sufentanil injection continued to increase, and other narcotic drugs were relatively stable. Sufentanil injection, oxycodone
sustained-release tablets, morphine sustained-release tablets and fentanyl transdermal patch had a relatively high DDC. The B/A of all
narcotic drugs were close to 1 in 2018, which meant better synchronization of economic and social benefits. Conclusion: The
consumption of narcotics in our hospital has been increasing year by year. The application basically meets the relevant standards and
treatment specifications, but it still needs to be strengthened.

Key words: narcotics, defined daily dose system, defined daily cost, B/A, rational application of drugs